Ancell, Kristin K.
Vanderbilt University Medical Center
3 papers on CoChat
Most cited papers
- Verified
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis
Wang, D. Y., Salem, J.-E., Cohen, J. V., Chandra, S., Menzer, C., Ye, F., Zhao, S., Das, S., Beckermann, K. E., Ha, L., et al. (2018) · JAMA Oncology
Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions
Cited by 2,674
- Verified
Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma
Pollack, M. H., Betof, A., Dearden, H., Rapazzo, K., Valentine, I., Brohl, A. S., Ancell, K. K., Long, G. V., Menzies, A. M., Eroglu, Z., et al. (2018) · Annals of Oncology
Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions
Cited by 393
- Verified
Association of Anti–Programmed Cell Death 1 Cutaneous Toxic Effects With Outcomes in Patients With Advanced Melanoma
Quach, H. T., Dewan, A. K., Davis, E. J., Ancell, K. K., Fan, R., Ye, F., & Johnson, D. B. (2019) · JAMA Oncology
Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management
Cited by 107
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free